Approved for Nadolol tablets, USP is indicated for the long-term management of patients with angina pectoris.. Nadolol tablets, USP is a nonselective beta-adrenergic receptor blocking agent. Clinical pharmacology studies have demonstrated beta-blocking activity by showing (1) reduction in heart rate and… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA…
Loading full data from Know Your Drugs Institute…